ACM
PFE icon

Advance Capital Management’s Pfizer PFE Stock Holding History

Advance Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555K Buy
23,042
+10,827
+89% +$283K 0.02% 111
2026
Q1 		$343K Buy
12,215
+3,486
+40% +$92.8K 0.01% 131
2025
Q4 		$217K Hold
8,729
– – 0.01% 161
2025
Q3 		$222K Sell
8,729
-11
-0.1% -$272 0.01% 159
2025
Q2 		$212K Buy
8,740
+11
+0.1% +$257 0.01% 157
2025
Q1 		$221K Sell
8,729
-479
-5% -$12.5K 0.01% 147
2024
Q4 		$244K Sell
9,208
-744
-7% -$20.2K 0.01% 133
2024
Q3 		$288K Sell
9,952
-235
-2% -$6.86K 0.01% 118
2024
Q2 		$285K Sell
10,187
-105
-1% -$2.89K 0.01% 120
2024
Q1 		$286K Buy
10,292
+115
+1% +$3.19K 0.02% 114
2023
Q4 		$293K Buy
10,177
+391
+4% +$11.8K 0.02% 97
2023
Q3 		$325K Buy
9,786
+39
+0.4% +$1.38K 0.03% 88
2023
Q2 		$358K Sell
9,747
-1,428
-13% -$55.6K 0.04% 80
2023
Q1 		$456K Sell
11,175
-47
-0.4% -$2.03K 0.08% 58
2022
Q4 		$575K Sell
11,222
-127
-1% -$6.09K 0.08% 53
2022
Q3 		$497K Buy
11,349
+104
+0.9% +$5.05K 0.06% 46
2022
Q2 		$590K Buy
11,245
+384
+4% +$19.6K 0.07% 35
2022
Q1 		$562K Buy
10,861
+335
+3% +$17.4K 0.07% 42
2021
Q4 		$622K Buy
+10,526
New +$522K 0.13% 35

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Advance Capital Management's PFE Position: Q2 2026 in Review

Advance Capital Management increased its Pfizer (PFE) stake by 89% in Q2 2026, buying an estimated $283K and bringing the position to 23,042 shares worth $555K. The position accounts for 0.02% of the portfolio, ranked #111.

Advance Capital Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $622K in Q4 2021. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Advance Capital Management held 23,042 shares of Pfizer worth $555K as of Q2 2026.
  • Advance Capital Management bought 10,827 Pfizer shares in Q2 2026, an estimated $283K.
  • Pfizer made up 0.02% of Advance Capital Management's portfolio in Q2 2026, its #111 holding.
  • Advance Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Advance Capital Management's Pfizer position peaked at $622K in Q4 2021.
  • 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Advance Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.